Shenzhen Salubris Pharmaceuticals Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 887.51 million compared to CNY 935.24 million a year ago. Revenue was CNY 887.51 million compared to CNY 935.24 million a year ago.

Net income was CNY 210.95 million compared to CNY 237.42 million a year ago. Basic earnings per share from continuing operations was CNY 0.19 compared to CNY 0.22 a year ago. Diluted earnings per share from continuing operations was CNY 0.19 compared to CNY 0.22 a year ago.